STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,680,000 | -17.1% | 346,190 | -35.0% | 4.86% | -3.1% |
| Q1 2023 | $4,438,974 | -0.4% | 532,890 | +10.4% | 5.02% | +18.1% |
| Q4 2022 | $4,457,075 | -33.6% | 482,890 | -7.6% | 4.25% | -39.4% |
| Q3 2022 | $6,710,000 | -3.6% | 522,550 | -0.9% | 7.00% | -10.3% |
| Q2 2022 | $6,964,000 | -37.2% | 527,150 | 0.0% | 7.81% | -23.5% |
| Q1 2022 | $11,097,000 | -12.2% | 527,150 | 0.0% | 10.20% | +3.3% |
| Q4 2021 | $12,646,000 | – | 527,150 | – | 9.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |